Afobazol Retard 30 mg N20 tablets

Afobazol Retard, 30 mg prolonged-release coated tablets

Afobazol Retard composition

Active ingredient: Each tablet contains 30 mg fabomotizole (in the form of fabomotizole dihydrochloride
).

Contraindications

Individual hypersensitivity to fabomotizole and/or any of the excipients of the product. Intolerance to galactose, lactase deficiency, or glucose-galactose malabsorption. Pregnancy and breastfeeding. Age under 18 years.
If you have any of the conditions listed above, you should consult your doctor before using the medicine.

Use during pregnancy and breastfeeding

Taking АFOBAZOL RETARD during pregnancy is contraindicated. During breastfeeding, if taking the product is necessary, breastfeeding should be discontinued.
Before using АFOBAZOL RETARD, consult your doctor if you are pregnant or think you may be pregnant, or if you plan to become pregnant.

Directions for use and dosage

Oral use.
1 tablet once daily, in the morning, regardless of food intake.
The duration of the treatment course is 2–4 weeks.
If there is no improvement after treatment, or if symptoms worsen, or if new symptoms appear, you should consult a doctor.
Use the product only for the indications, method of administration, and dosages specified in the instructions.